SCHEMBL22915151

SCHEMBL22915151

O=C1O[C@@](c2ccccc2)(C(F)(F)F)Nc2cc(Cl)ccc21

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.52
MAPT P10636 2/20 0.42
CES1 P23141 1/20 0.39
LMNA P02545 2/20 0.38
NPSR1 Q6W5P4 2/20 0.38
POLB P06746 1/20 0.38
ALDH1A1 P00352 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
PDK2 Q15119 3/20 0.38
CHEK1 O14757 1/20 0.38
NR1I2 O75469 1/20 0.36
NR3C1 P04150 1/20 0.36
PGR P06401 1/20 0.36
ADRB1 P08588 1/20 0.36
ADORA3 P0DMS8 1/20 0.36
CNR1 P21554 1/20 0.36
SLC6A2 P23975 1/20 0.36
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22915162 0.89 TP53 (0.49) TP53MAPTCES1LMNANPSR1
SCHEMBL22915139 0.84 TP53 (0.52) TP53MAPTCES1LMNANPSR1
SCHEMBL22915143 0.84 TP53 (0.55) TP53MAPTLMNANPSR1POLB
SCHEMBL22915127 0.83 TP53 (0.43) TP53MAPTLMNANPSR1POLB
SCHEMBL22915137 0.83 TP53 (0.52) TP53LMNANPSR1POLBALDH1A1
SCHEMBL22915160 0.83 TP53 (0.52) TP53LMNANPSR1POLBALDH1A1
SCHEMBL22915142 0.83 TP53 (0.43) TP53MAPTLMNANPSR1POLB
SCHEMBL22915164 0.81 TP53 (0.74) TP53MAPTLMNANPSR1POLB
SCHEMBL22915211 0.80 TP53 (0.42) TP53MAPTLMNANPSR1POLB
SCHEMBL22915182 0.77 TP53 (0.50) TP53MAPTLMNANPSR1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11440892-B2 Substituted dihydrobenzoxazinones, dihydroquinolones, and methods of their use and synthesis NORTHWESTERN UNIVERSITY (US) 2022-09-13 US disclosed
US-20210024473-A1 SUBSTITUTED DIHYDROBENZOXAZINONES, DIHYDROQUINOLONES, AND METHODS OF THEIR USE AND SYNTHESIS NORTHWESTERN UNIVESITY 2021-01-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210024473-A1 SUBSTITUTED DIHYDROBENZOXAZINONES, DIHYDROQUINOLONES, AND METHODS OF THEIR USE AND SYNTHESIS NQO1, DHPS, NQO2 TP53 2011/4885MAPT 3887/4885CES1 1436/4885
US-11440892-B2 Substituted dihydrobenzoxazinones, dihydroquinolones, and methods of their use and synthesis NQO1, DHPS, NQO2 TP53 2011/4885MAPT 3887/4885CES1 1436/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.